http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0d68e73948b6203e6cce0d864bee0fc
Outgoing Links
Predicate | Object |
---|---|
family-name | Lainchbury |
name | Michael Lainchbury |
given-name | Michael |
organization-name | Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK Charles River Laboratories, 8-9 Spire Green, Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom Authors' Affiliations: 1Division of Cancer Therapeutics, 2Division of Radiotherapy and Imaging, The Institute of Cancer Research, Sutton; and 3Sareum Ltd, Cambridge, United Kingdom Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK Argenta, Early Discovery Charles River, 7/9 Spire Green Centre, Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG U. K. |
Incoming Links
Total number of triples: 19.